Speaker(s):
Angela Schreck, RRT-NPS, Staff Member, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Describe the function and indications for HFOV 3100A in the neonatal population
- Explain the difference between PPHN and MAS and treatment differences for each disease when using the HFOV 3100A in the neonatal population
- Describe the ABG and CXR interpretation based on PPHN and MAS and how to manage a patient correctly when transitioning from conventional to HFOV ventilation
- Recognize the indications for using HFJV over HFOV and the differences between the two
- Describe the settings for HFJV and how to adequately apply and use in a neonatal patient
- Indications for usage of conventional settings when using HFJV and describe what they can be used to help with
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Dr. Ronald Wong, MD, Katie Ritz, BS, RRT-NPS, Mark Williams, RN, Katelyn Green have no identified disclosures.
CE Committe Member/ Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPPA complaint.
Commerical Support for this Session.
None.
Session date:
03/20/2024 - 7:00am to 8:00am EDT
Location:
Geisinger Medical Center
Danville, PA
17822
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit